Table of Contents >> Show >> Hide
- Who Is Sarika Ramachandran, MD?
- Education and Training
- Clinical Focus: Autoimmune and Rheumatologic Skin Disease
- Advocacy for Skin of Color and Inclusive Dermatology
- Research and Publications
- What Patients Can Expect When Seeing Dr. Ramachandran
- Why Physicians Like Sarika Ramachandran, MD Matter
- Experiences and Insights Related to Working With Specialists Like Sarika Ramachandran, MD
When people think about dermatology, they often picture acne creams, wrinkle serums, and the occasional suspicious mole.
But for many patients, skin care is far more complexand sometimes life-changing. That’s the world in which
Sarika Ramachandran, MD, a board-certified dermatologist at Yale Medicine and associate professor
at Yale School of Medicine, spends her days.
Dr. Ramachandran doesn’t just treat rashes and routine breakouts. Her clinical and research focus centers on
autoimmune and rheumatologic skin diseases, including cutaneous lupus, scleroderma, morphea, and
other conditions that link the skin to the immune system and internal organs.
She also works to close long-standing gaps in how dermatology represents and cares for patients with
skin of color.
In other words, if your immune system and your skin are having a very dramatic, very complicated conversation,
Dr. Ramachandran is one of the specialists you want in the room.
Who Is Sarika Ramachandran, MD?
Dr. Sarika Manoj Ramachandran is a dermatologist at Yale Medicine Dermatology in Branford, Connecticut,
where she serves as the medical director of the Branford practice and cares for children, adolescents, and adults.
On the academic side, she is an Associate Professor of Dermatology and
Vice Chair of Collaborative Excellence and Faculty Engagement at Yale School of Medicineroles that
reflect both her clinical expertise and her focus on teamwork and mentorship.
Her career sits at the crossroads of:
- Clinical care for complex autoimmune and rheumatologic skin conditions
- Research on diseases such as lupus, dermatomyositis, morphea, and related disorders
- Education and advocacy for better representation of skin of color in medical materials
That mix puts her in a relatively rare group: dermatologists who are equally comfortable at the exam table, in
the classroom, and in the research lab.
Education and Training
Dr. Ramachandran completed both her undergraduate and medical degrees at
SUNY Stony Brook in New York, earning a BS followed by an MD.
She went on to train in dermatology and is certified by the American Board of Dermatology,
ensuring that she meets rigorous national standards in her specialty.
Over the course of her career, she has held academic and clinical roles at leading institutions, including
New York University and Massachusetts General Hospital–Harvard Medical School, contributing to work on conditions
such as oral allergy syndrome (also known as pollen–food allergy syndrome).
Her current home base is Yale, where she combines patient care, teaching, and research.
Clinical Focus: Autoimmune and Rheumatologic Skin Disease
Plenty of dermatologists treat eczema, acne, and sun damage. Dr. Ramachandran certainly sees those issues, but she
has developed a particular expertise in autoimmune and connective tissue diseases that affect the skin
and, often, internal organs.
Cutaneous Lupus and Dermatomyositis
Cutaneous lupus and dermatomyositis are inflammatory diseases where the immune system mistakenly attacks healthy
tissuesoften the skinand can be associated with serious systemic involvement. Dr. Ramachandran has published
and co-authored work on these conditions, including reviews of lupus and dermatomyositis and studies that examine
consultation patterns and disease characteristics in real-world clinical settings.
Because these diseases can affect muscles, joints, and internal organs, patients benefit from a specialist who
understands both dermatology and rheumatology. At Yale, she works within a coordinated
dermatology–rheumatology program, so patients can be evaluated by multiple specialists in a single,
integrated setting.
Scleroderma, Morphea, and Connective Tissue Disease
Scleroderma and morphea involve thickening, hardening, or scarring of the skin, sometimes with involvement of blood
vessels and internal organs. As part of the Yale Scleroderma Program, Dr. Ramachandran collaborates
with rheumatologists, cardiologists, anesthesiologists, and other specialists to manage these complex cases.
Her research includes studying morphea and exploring new treatments for autoimmune skin diseases, reflecting an
ongoing commitment to better long-term outcomes and more precise therapies.
General Dermatology with a Subspecialty Lens
In clinic, Dr. Ramachandran still treats many of the conditions people commonly associate with dermatology:
acne, eczema, psoriasis, warts, rashes, and more.
But her added expertise means that when something looks “routine” yet behaves unusually, she is particularly attuned
to the possibility of an underlying autoimmune or systemic issue.
Think of it as going to a mechanic who can change your oil but is also a specialist in hybrid engines: routine
maintenance is covered, but if something complicated is brewing under the hood, they’re ready for that too.
Advocacy for Skin of Color and Inclusive Dermatology
One of the most important threads in Dr. Ramachandran’s work is her focus on how dermatology serves patients with
skin of color. She is a fellow of the Skin of Color Society and participates in
mentorship initiatives aimed at improving representation within the field.
She has co-authored research documenting ongoing gaps in how skin of color appears in medical education materials
and patient resourcesfor example, analyzing question banks, educational images, and patient brochures to see how
often darker skin tones are represented.
These studies highlight that many training tools still skew toward lighter skin types, which can delay diagnosis
or mislead clinicians when they encounter conditions in patients with darker complexions.
By calling out these gaps and quantifying them, Dr. Ramachandran and her colleagues are pushing the field toward
more inclusive, accurate, and equitable dermatologic care.
Research and Publications
Beyond her clinical practice, Dr. Ramachandran is an active researcher. Her publications and collaborations span:
-
Autoimmune skin disease – including cutaneous lupus, dermatomyositis, and related connective
tissue disorders. -
Skin of color and representation – reanalyzing how educational and patient materials depict
dermatologic conditions across diverse skin tones. -
Rare or challenging clinical presentations – such as case reports of cosmetic procedure
complications (for example, nodules following a Brazilian butt lift) and other unusual dermatologic findings.
Her work appears in respected journals including the Journal of the American Academy of Dermatology,
Archives of Dermatological Research, the Journal of Investigative Dermatology, and others.
She is also a medical reviewer and expert contributor for health publications like Healthline, Medical News Today, and
PsychCentralhelping ensure online health information about skin disease is medically accurate and up-to-date.
What Patients Can Expect When Seeing Dr. Ramachandran
While every patient visit is unique, several themes show up repeatedly in descriptions of Dr. Ramachandran’s practice:
A Team-Based Approach
Many of the conditions she treatssuch as lupus, scleroderma, and dermatomyositisstraddle multiple organ systems.
For that reason, her clinic is integrated with rheumatology and other specialties, particularly through programs
like the Yale Scleroderma Program.
Instead of bouncing between offices, patients can have their skin, joints, and systemic symptoms evaluated in a
coordinated fashion. This setup makes it easier to choose treatments that help the skin without worsening other
aspects of the diseaseand vice versa.
Evidence-Based Decisions (with Real-World Practicality)
As an academic dermatologist, Dr. Ramachandran is immersed in the latest research, but the goal is always practical:
finding a treatment plan that patients can realistically follow. For chronic autoimmune conditions, that might mean
combining topical therapies, systemic medications, lifestyle adjustments, and close monitoring for side effects or
disease flares.
Attention to Long-Term Outcomes
Autoimmune skin diseases can leave scars, pigment changes, and joint or mobility problems if not treated early and
aggressively enough. Dr. Ramachandran’s emphasis on early recognition and multidisciplinary care aims to prevent
complications like contractures and long-term disability whenever possible.
Why Physicians Like Sarika Ramachandran, MD Matter
Complex skin diseases are rarely “just skin deep.” They can affect confidence, comfort, career, and overall health.
Specialists like Dr. Ramachandran sit at the intersection of those realities:
- They see the skin as a window into systemic disease.
- They collaborate across disciplines to address whole-person health.
- They push for better representation so that medical training reflects every patient, not just a narrow slice.
For patients navigating autoimmune or rheumatologic skin disease, that combination of clinical skill, research
insight, and advocacy can significantly influence both day-to-day quality of life and long-term outcomes.
Experiences and Insights Related to Working With Specialists Like Sarika Ramachandran, MD
To understand the impact of a physician like Dr. Ramachandran, it helps to zoom out from titles and publications and
look at what the experience of care can feel likeboth for patients and for the broader health-care system.
The Patient Who Thought It Was “Just a Rash”
Imagine a patient in their 30s who develops a persistent rash on sun-exposed areas: the face, neck, and arms. At
first, it’s brushed off as “sensitive skin” or “maybe rosacea.” Over-the-counter creams don’t help. The rash worsens,
fatigue creeps in, and joint pain starts to show up on cold mornings.
By the time this patient sits in a rheumatologic dermatology clinic, they are worriedand exhausted from not being
believed. A specialist like Dr. Ramachandran approaches that story differently. The rash isn’t just a cosmetic
concern; it may be a clue to cutaneous lupus or another autoimmune condition. A detailed history,
targeted bloodwork, and sometimes a skin biopsy help connect the dots between the skin findings and systemic symptoms.
When a diagnosis is finally made, the patient isn’t simply handed a prescription. They are walked through what the
disease means, which symptoms to watch for, and how treatmentsfrom topical medications to immunomodulating pills
or injectionsmight help control both skin and systemic disease. That combination of explanation and evidence-based
treatment is often what transforms anxiety into a sense of agency.
The Challenge of Autoimmune Flares
Autoimmune skin diseases tend to wax and wane. Flares might be triggered by infections, medications, stress, or even
sunlight exposure. In real life, that means patients might have weeks where everything feels stable, followed by a
sudden eruption of lesions, fatigue, or pain.
A clinician whose practice is built around these patterns knows to create flexible care plans: easier access for
urgent appointments, clear instructions on what to do when symptoms worsen, and a willingness to adjust therapies as
new data emerges. In multidisciplinary programs like Yale’s, dermatologists and rheumatologists can coordinate
changes together, rather than leaving the patient to relay messages between offices.
Representation Matters in the Exam Room, Too
Another recurring theme in experiences around dermatologic care is representationboth in the waiting room and in the
educational materials. Patients with darker skin tones may have spent years seeing brochures and textbook images that
don’t reflect how conditions look on their skin. That can quietly erode trust: “If my skin doesn’t appear in the
teaching slides, will my symptoms be taken seriously?”
Research co-authored by Dr. Ramachandran and colleagues has documented these gaps, finding that skin of color remains
underrepresented in widely used educational and patient materials.
For patients, knowing that their dermatologist is working to change that landscape can be reassuring. It signals that
the clinician is aware of structural inequities and is actively pushing back against them.
The Perspective of Trainees and Colleagues
From the viewpoint of residents, fellows, and early-career dermatologists, mentors like Dr. Ramachandran play an
outsized role. Through professional societies such as the Skin of Color Society and academic mentorship programs,
she and others help shape how the next generation learns to recognize disease in all skin tones and to think
beyond narrowly defined textbook presentations.
The ripple effect is significant: every trainee who learns to identify lupus, dermatomyositis, or morphea earlyand
in diverse patientsis a clinician who can reduce misdiagnosis, shorten time to treatment, and potentially prevent
long-term complications for hundreds of people over a career.
What This Means for Patients and Families
For patients and families, the practical takeaway is straightforward but powerful:
-
If you live with a complex autoimmune or rheumatologic condition that affects your skin, seeking out a
dermatologist with specific expertise in those diseases can make a real difference. -
If you have skin of color, asking whether a clinic is attentive to representation and experienced in treating
diverse skin types is a fairand importantquestion. -
If your symptoms don’t fit the “classic” pictures you see online, that doesn’t mean they’re any less real.
Specialists like Dr. Ramachandran are used to seeing the complicated, the atypical, and the not-so-textbook.
While no single physician can solve every challenge in autoimmune dermatology or health inequity, clinicians like
Sarika Ramachandran, MD, show how much can be accomplished when clinical care, research, and
advocacy move in the same direction.